|
Index of reports
> Cases with Neutropenia (187)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Dexamethasone where reactions include neutropenia. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 187 Next >>
Possible Dexamethasone side effects in 52 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24
Patient: 52 year old female
Reactions: Tumour Lysis Syndrome, Posterior Reversible Encephalopathy Syndrome, Insomnia, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: according to larson regimen
Indication: B Precursor Type Acute Leukaemia
Daunorubicin HCL
Dosage: according to larson regimen
Indication: B Precursor Type Acute Leukaemia
Daunorubicin HCL
Dosage: at 50% dosage
Dexamethasone
Indication: Premedication
Methylprednisolone Sodium Succinate
Indication: B Precursor Type Acute Leukaemia
Prednisone TAB
Dosage: according to larson regimen
Indication: B Precursor Type Acute Leukaemia
Vincristine
Dosage: according to larson regimen
Indication: B Precursor Type Acute Leukaemia
Other drugs received by patient: Ondansetron; Voriconazole; Morphine Sulfate; Morphine
Possible Dexamethasone side effects in 55 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-18
Patient: 55 year old female
Reactions: Malaise, Neutropenia, Wound Infection
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Breast Cancer
Dexamethasone
Dosage: 8 mg
Dexamethasone
Dosage: 8 mg
Administration route: Oral
Indication: Supportive Care
Docetaxel
Indication: Breast Cancer
Possible Dexamethasone side effects in male
Reported by a physician from United States on 2012-08-15
Patient: male
Reactions: Streptococcal Bacteraemia, Otitis Media, Neutropenia, Pyrexia, Sinusitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Bms833923
Dosage: 90 mg
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-05-20
Dexamethasone
Dosage: 40 mg
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-04-01
End date: 2011-04-05
Dexamethasone
Administration route: Oral
Start date: 2011-04-01
Lenalidomide
Dosage: 10 mg
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-04-01
End date: 2011-04-05
Lenalidomide
Administration route: Oral
Start date: 2011-04-01
Other drugs received by patient: Aspirin; Neurontin; Multi-Vitamins; Senokot; Clonazepam; Ativan; Calcium; Neurontin; Calcium and Vitamin D; Magnesium; Clonopin
Possible Dexamethasone side effects in 64 year old male
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-08-08
Patient: 64 year old male
Reactions: Pneumonia, Neutropenia, Leukaemia Plasmacytic, Disease Progression
Adverse event resulted in: death
Drug(s) suspected as cause:
Bortezomib
Indication: Leukaemia Plasmacytic
Cyclophosphamide
Dosage: 1 g
Indication: Leukaemia Plasmacytic
Dexamethasone
Dosage: 40 mg
Dexamethasone
Dosage: 40 mg
Indication: Leukaemia Plasmacytic
Lenalidomide
Dosage: 25 mg
Indication: Leukaemia Plasmacytic
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-06
Patient:
Reactions: Anaphylactic Reaction, Pyrexia, Headache, Hyperhidrosis, Oedema Peripheral, Cough, Muscle Spasms, Diverticular Perforation, Back Pain, Pneumonia, Anaemia, Insomnia, Neutropenia, Stridor, Chills, Constipation, Hypokalaemia, Disease Progression, Fatigue, Dizziness, Thrombocytopenia, Enteritis, Dyspnoea, Nausea, Lymphopenia, Atrial Fibrillation, Febrile Neutropenia, Rash, Lung Disorder, Diarrhoea, Arthralgia, Sepsis, Bradycardia, Asthenia
Drug(s) suspected as cause:
Dexamethasone
Dosage: 40 milligram
Administration route: Oral
Indication: Multiple Myeloma
Elotuzumab
Dosage: 5, 10 and 20 mg/kg
Indication: Multiple Myeloma
Elotuzumab
Dosage: 5, 10 and 20 mg/kg
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Possible Dexamethasone side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-06
Patient: female
Reactions: Diabetes Mellitus, Tricuspid Valve Incompetence, Walking AID User, Malaise, Nervousness, Breast Cancer, Pancytopenia, Left Ventricular Hypertrophy, Toxic Nodular Goitre, Nasal Congestion, Oesophageal Rupture, Mammary Duct Ectasia, HIP Fracture, Diverticulum, Swelling, Neutropenia, Neutrophil Count Decreased, Osteoporosis, Folliculitis, Fall, Gastric Ulcer, Haematemesis, Hyperparathyroidism, Chest Pain, Aortic Arteriosclerosis, Perineurial Cyst, Thyroid Mass, Depression, Decreased Appetite, Renal Failure Acute, Dyspnoea, Musculoskeletal Pain, Streptococcus Test Positive, Syncope, Pulmonary Valve Incompetence, Impaired Healing, Arthralgia, Mitral Valve Incompetence, Sepsis, Dysaesthesia, Gait Disturbance, Respiratory Tract Infection, Leukopenia, Vitamin D Deficiency, Weight Decreased, Goitre, Lower Limb Fracture, Herpes Zoster, Hypomagnesaemia, Uterine Leiomyoma, Metastatic Lymphoma, Breast Hyperplasia, Radiculopathy, Chest Discomfort, Stomatitis, Pneumonia, Pain in Extremity, Breast Discharge, Anaemia, Hypoaesthesia, Convulsion, Insomnia, Nervous System Disorder, Aortic Valve Incompetence, Dyslipidaemia, Pain, Suicidal Ideation, Intraductal Papilloma of Breast, Weight Increased, Fatigue, Neuropathy Peripheral, Thrombocytopenia, Sinusitis, RIB Fracture, Polyp, Bone Lesion, Urinary Tract Infection, Hypercalcaemia, Deformity, Osteoarthritis, Psychotic Disorder, Osteonecrosis of JAW, Neoplasm Malignant, Fibrous Dysplasia of Bone, Microalbuminuria, Bronchitis, Sinus Tachycardia, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Actos
Dosage: 30 mg, qhs
Indication: Diabetes Mellitus
Aredia
Dosage: 90 mg, qmo over 4 hrs
Indication: Multiple Myeloma
Start date: 2001-10-01
End date: 2002-01-01
Aredia
Start date: 2008-07-07
Dexamethasone
Zometa
Dosage: 4 mg, q2mo infusion over 25 mins every other month
Indication: Multiple Myeloma
End date: 2005-07-21
Other drugs received by patient: Cytoxan; Aspirin; Prednisone; Hepatitis B Vaccine; Velcade; Procrit / 00909301 /; Cyclophosphamide; Alkeran; Vaccine / Pertussis / Tetanus / Diphtheria / ^cng^; Pneumovax 23; Enalapril Maleate; Norvasc; Revlimid; Decadron Phosphate; Chemotherapeutics NOS; Vincristine + Adriamycin + Dexamethasone; Pentamidine; Potassium Chloride; Thalidomide; Polio-Vaccine; Melphalan Hydrochloride; Fortamet; Crestor; Magnesium Oxide; Xanax; Benadryl; Doxil; Avalide; Influenza Vaccine; Augmentin '125'; Metformin Hydrochloride
Possible Dexamethasone side effects in
Reported by a physician from United States on 2012-08-02
Patient:
Reactions: Electrocardiogram QT Prolonged, Hypokalaemia, Hypocalcaemia, Thrombocytopenia, Lethargy, Pneumonia, Nausea, Hyperglycaemia, Atrial Fibrillation, Febrile Neutropenia, Arthralgia, Diarrhoea, Dehydration, Neutropenia, Asthenia, Leukopenia
Drug(s) suspected as cause:
Dexamethasone
Indication: Multiple Myeloma
Lenalidomide
Dosage: 5 or 10mg (daily,days 1-21 of ea cycle)
Administration route: Oral
Indication: Multiple Myeloma
Treanda
Dosage: 75 or 100mg/m2 (day 1 and 2 of ea cycle)
Indication: Multiple Myeloma
Other drugs received by patient: Gastroprotectant; Acetylsalicylic Acid SRT
Possible Dexamethasone side effects in 58 year old male
Reported by a health professional (non-physician/pharmacist) on 2012-08-02
Patient: 58 year old male, weighing 77.0 kg (169.4 pounds)
Reactions: Haemoglobin Decreased, White Blood Cell Count Decreased, Platelet Count Decreased, Neutropenia
Drug(s) suspected as cause:
Asparaginase (Unspecified) (Asparginase) (Unknown)
Indication: Chemotherapy
Start date: 2012-03-12
Cyclophosphamide
Indication: Chemotherapy
Start date: 2012-03-12
Dexamethasone
Indication: Chemotherapy
Start date: 2012-03-12
Doxorubicin HCL
Indication: Chemotherapy
Start date: 2012-03-12
Isavuconazole (Isavuconazole)
Dosage: three times daily, intravenous (not otherwise specified)
Indication: Fungal Infection
Start date: 2012-02-07
End date: 2012-02-09
Vincristine
Indication: Chemotherapy
Start date: 2012-03-12
Other drugs received by patient: Metronidazole; Ciprofloxacin
Possible Dexamethasone side effects in 64 year old male
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-08-01
Patient: 64 year old male
Reactions: Pneumonia, Disease Recurrence, Neutropenia, Leukaemia Plasmacytic
Adverse event resulted in: death
Drug(s) suspected as cause:
Bortezomib
Dosage: 1,3 mg/m2 i.v days 1, 4 8, 11, intravenous (not otherwise specified)
Indication: Leukaemia Plasmacytic
Dexamethasone
Dosage: 40 mg, days 1, 2 4, 5-8, 9-11, 12, 40 mg, days 1, 7, 14, 21
Indication: Leukaemia Plasmacytic
Lenalidomide
Dosage: 25 mg, days 1-14
Indication: Leukaemia Plasmacytic
Other drugs received by patient: Cyclophosphamide
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-31
Patient:
Reactions: Mantle Cell Lymphoma Refractory, Skin Toxicity, Neurotoxicity, Neuropathy Peripheral, Hepatotoxicity, Cardiotoxicity, Thrombocytopenia, Renal Disorder, Drug Effect Decreased, Gastrointestinal Toxicity, Anaemia, Febrile Neutropenia, Toxicity To Various Agents, Mantle Cell Lymphoma, Lung Disorder, Neutropenia, Infection
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Chlorambucil
Dosage: from day 20 to 29.
Indication: Mantle Cell Lymphoma
Dexamethasone
Dosage: day 1 to 4
Indication: Mantle Cell Lymphoma
Doxorubicin Hydrochloride
Dosage: as a continuous infusion from day 1 to 4
Doxorubicin Hydrochloride
Dosage: as a continuous infusion from day 1 to 4
Indication: Mantle Cell Lymphoma
Rituximab
Dosage: on day 1 (and day 8 of cycle 1)
Indication: Mantle Cell Lymphoma
Velcade
Dosage: on days 1, 4, 8 and 11
Indication: Mantle Cell Lymphoma
Possible Dexamethasone side effects in 70 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-07-30
Patient: 70 year old female
Reactions: Renal Impairment, Hyperkalaemia, Anaemia, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-09-24
End date: 2010-11-03
Dexamethasone
Indication: Multiple Myeloma
Start date: 2010-09-24
End date: 2010-11-03
Revlimid
Dosage: 10 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-09-24
End date: 2010-11-03
Possible Dexamethasone side effects in male
Reported by a individual with unspecified qualification from United States on 2012-07-30
Patient: male, weighing 15.6 kg (34.3 pounds)
Reactions: Neutropenia, Pyrexia
Drug(s) suspected as cause:
Daunorubicin HCL
Dosage: 47.25 mg
End date: 2012-07-26
Dexamethasone
Dosage: 42 mg
End date: 2012-07-25
Methotrexate
Dosage: 24 mg
End date: 2012-07-24
PEG-L-Asparaginase (Pegaspargase, Oncospar)
Dosage: 1597.5 mg
End date: 2012-07-16
Vincristine Sulfate
Dosage: 2.85 mg
End date: 2012-07-26
Possible Dexamethasone side effects in
Reported by a individual with unspecified qualification from Spain on 2012-07-30
Patient:
Reactions: Colon Cancer, Pulmonary Embolism, Toxicity To Various Agents, Multiple Myeloma, Herpes Zoster, Death, Neuropathy Peripheral, Gastrointestinal Disorder, Neutropenia, Thrombocytopenia, Deep Vein Thrombosis, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bortezomib
Dosage: 1.3mg/m2 on days 1,4,8 and 11 q 3 weeks
Indication: Multiple Myeloma
Dexamethasone
Dosage: 40mg on days 1-4 and 9-12 at 4-week intervals
Administration route: Oral
Indication: Multiple Myeloma
Thalomid
Dosage: 200mg daily (escalating doses in the first cycle)
Administration route: Oral
Indication: Multiple Myeloma
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-23
Patient:
Reactions: Electrocardiogram QT Prolonged, Hypokalaemia, Hypocalcaemia, Thrombocytopenia, Lethargy, Pneumonia, Nausea, Hyperglycaemia, Febrile Neutropenia, Atrial Fibrillation, Arthralgia, Diarrhoea, Dehydration, Neutropenia, Asthenia, Leukopenia
Drug(s) suspected as cause:
Bendamustine Hydrochloride
Dosage: 75 or 100mg/m2
Indication: Multiple Myeloma
Dexamethasone
Indication: Multiple Myeloma
Revlimid
Dosage: 5 or 10mg
Administration route: Oral
Indication: Multiple Myeloma
Other drugs received by patient: Gastroprotectant; Aspirin
Possible Dexamethasone side effects in 72 year old female
Reported by a health professional (non-physician/pharmacist) from Austria on 2012-07-20
Patient: 72 year old female
Reactions: Bone Pain, Polyuria, Peripheral Sensory Neuropathy, Constipation, Disease Progression, Oedema Peripheral, Dermatitis Bullous, Muscle Spasms, Decreased Appetite, Spinal Fracture, Nausea, Anaemia, Muscular Weakness, Micturition Urgency, Haemoglobin Decreased, Diarrhoea, Visual Impairment, Neutropenia, Hypertension, Herpes Virus Infection, Leukopenia
Drug(s) suspected as cause:
Dexamethasone
Dosage: 40 mg
Administration route: Oral
Indication: Multiple Myeloma
Dexamethasone
Dosage: 12 mg
Administration route: Oral
End date: 2010-03-01
Dexamethasone
Dosage: 40 mg
Administration route: Oral
Dexamethasone
Dosage: 20 mg
Administration route: Oral
Lenalidomide
Dosage: 25 mg
Indication: Multiple Myeloma
Lenalidomide
Dosage: 15 mg
Lenalidomide
Dosage: 10 mg
Lenalidomide
Dosage: 5 mg
End date: 2010-03-01
Pamidronate Disodium
Indication: Multiple Myeloma
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-19
Patient:
Reactions: Mantle Cell Lymphoma Refractory, Skin Toxicity, Neurotoxicity, Neuropathy Peripheral, Hepatotoxicity, Cardiotoxicity, Thrombocytopenia, Drug Effect Decreased, Renal Disorder, Gastrointestinal Toxicity, Anaemia, Febrile Neutropenia, Toxicity To Various Agents, Mantle Cell Lymphoma, Lung Disorder, Neutropenia, Infection
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Chlorambucil
Dosage: from day 20 to 29.
Indication: Mantle Cell Lymphoma
Dexamethasone
Dosage: day 1 to 4
Indication: Mantle Cell Lymphoma
Doxorubicin HCL
Dosage: as a continuous infusion from day 1 to 4
Indication: Mantle Cell Lymphoma
Rituximab
Dosage: on day 1 (and day 8 of cycle 1)
Indication: Mantle Cell Lymphoma
Velcade
Dosage: on days 1, 4, 8 and 11
Indication: Mantle Cell Lymphoma
Possible Dexamethasone side effects in male
Reported by a physician from Japan on 2012-07-18
Patient: male
Reactions: Bronchopneumonia, Disseminated Intravascular Coagulation, Pyrexia, Constipation, Herpes Zoster, Neuropathy Peripheral, C-Reactive Protein Increased, Thrombocytopenia, Blood Creatinine Increased, Cardiac Failure Congestive, Decreased Appetite, Prothrombin Time Ratio Increased, Dyspnoea, Pneumonia, Anaemia, Muscular Weakness, Lobar Pneumonia, Haemoglobin Decreased, Cerebral Infarction, Sepsis, Platelet Count Decreased, Neutropenia, Neutrophil Count Decreased
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Dexamethasone
Dosage: 2.8571 milligram
Administration route: Oral
Start date: 2012-01-13
End date: 2012-02-03
Dexamethasone
Dosage: 2.8571 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-12-10
End date: 2012-01-07
Prednisolone
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-05-12
End date: 2011-05-25
Prednisolone
Dosage: 60 milligram
Administration route: Oral
Start date: 2011-05-26
End date: 2011-06-01
Prednisolone
Dosage: 10 milligram
Indication: Multiple Myeloma
Start date: 2012-02-09
End date: 2012-02-17
Prednisolone
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-03-31
End date: 2011-04-13
Prednisolone
Dosage: 60 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-03-24
End date: 2011-03-30
Prednisolone
Dosage: 10 milligram
Administration route: Oral
Start date: 2011-08-17
End date: 2012-02-08
Prednisolone
Dosage: 60 milligram
Administration route: Oral
Start date: 2011-04-21
End date: 2011-05-11
Revlimid
Dosage: 15 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-03-24
End date: 2011-04-13
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-08-17
End date: 2011-09-06
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-09-14
End date: 2011-10-03
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-10-12
End date: 2011-10-22
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2011-12-11
End date: 2011-12-31
Revlimid
Dosage: 15 milligram
Administration route: Oral
Start date: 2011-04-21
End date: 2011-05-11
Revlimid
Dosage: 5 milligram
Administration route: Oral
Start date: 2012-01-25
End date: 2012-02-11
Other drugs received by patient: Glufast; Warfarin Sodium; Famotidine; Mucosta; Flomax; Warfarin Sodium; Magnesium Oxide; Zometa; Lansoprazole; Magnesium Oxide; Slow-K; Glufast; Tamsulosin HCL; Humulin R; Warfarin Sodium; Tamsulosin HCL; SHA-Kanzo-TO; SHA-Kanzo-TO; Levothyroxine Sodium; Diovan; Slow-K; Warfarin Sodium; Mucosta; Diovan; Clarithromycin; Levothyroxine Sodium; Levothyroxine Sodium; Zometa
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-18
Patient:
Reactions: Pneumonia, Nausea, Lymphopenia, Hyperglycaemia, Anaemia, Febrile Neutropenia, Constipation, Renal Failure, Neuropathy Peripheral, Fatigue, Diarrhoea, Embolism, Neutropenia, Thrombocytopenia, Deep Vein Thrombosis
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 500 milligram/sq. meter
Indication: Multiple Myeloma
Dexamethasone
Dosage: 40 milligram
Indication: Multiple Myeloma
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Revlimid
Dosage: 15 milligram
Administration route: Oral
Velcade
Dosage: 1.3 milligram/sq. meter
Indication: Multiple Myeloma
Velcade
Dosage: 1.3 milligram/sq. meter
Possible Dexamethasone side effects in 68 year old male
Reported by a physician from United Kingdom on 2012-07-17
Patient: 68 year old male
Reactions: Neutropenia, Oxygen Saturation Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-06-22
Dexamethasone
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-06-22
Revlimid
Dosage: 10 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-06-22
Possible Dexamethasone side effects in
Reported by a physician from France on 2012-07-16
Patient:
Reactions: Pulmonary Toxicity, Gastrointestinal Toxicity, Nephropathy Toxic, Anaemia, Neurotoxicity, Neuropathy Peripheral, Hepatotoxicity, Sepsis, Cardiotoxicity, Neutropenia, Thrombocytopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Bortezomib
Dosage: drug: ps 341 on d1, 4, 8 and 11 of cycle 1.
Indication: Mantle Cell Lymphoma
Chlorambucil
Dosage: d20 to d29. one cycle every 35 days.
Indication: Mantle Cell Lymphoma
Dexamethasone
Dosage: from day 1 to 4.
Indication: Mantle Cell Lymphoma
Doxorubicin HCL
Dosage: continuous infusion for 4 days. form: infusion.
Indication: Mantle Cell Lymphoma
Mabthera
Dosage: day 1 (and day 8 for cycle 1).
Indication: Mantle Cell Lymphoma
Possible Dexamethasone side effects in
Reported by a physician from Austria on 2012-07-12
Patient:
Reactions: Bone Pain, Polyuria, Multiple Myeloma, Peripheral Sensory Neuropathy, Constipation, Oedema Peripheral, Dermatitis Bullous, Muscle Spasms, Decreased Appetite, Nausea, Anaemia, Muscular Weakness, Lumbar Vertebral Fracture, Micturition Urgency, Diarrhoea, Visual Impairment, Neutropenia, Hypertension, Herpes Virus Infection, Leukopenia
Drug(s) suspected as cause:
Dexamethasone
Dosage: 40 mg, on days 1-4, 9-12, and 17-20 for the first four cycles and on days 1-4 thereafter
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2004-06-01
End date: 2005-10-01
Dexamethasone
Dosage: 20 mg on days 1-4 of each cycle
Administration route: Oral
Dexamethasone
Dosage: 12 mg on days 1-4 of each cycle
Administration route: Oral
End date: 2010-03-01
Lenalidomide
Dosage: 25 mg, on days 1-21 of each 28-day cycle
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2005-11-01
Lenalidomide
Dosage: 15 mg daily on days 1-21
Administration route: Oral
End date: 2010-03-01
Lenalidomide
Dosage: 10 mg, daily on days 1-21
Administration route: Oral
Lenalidomide
Dosage: 5 mg, daily on days 1-21
Administration route: Oral
End date: 2010-03-01
Other drugs received by patient: Pamidronate Disodium
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-02
Patient:
Reactions: Neutropenia
Drug(s) suspected as cause:
Dexamethasone
Indication: T-Cell Lymphoma Stage IV
Elspar
Indication: T-Cell Lymphoma Stage IV
Etoposide
Indication: T-Cell Lymphoma Stage IV
Ifosfamide
Indication: T-Cell Lymphoma Stage IV
Methotrexate Sodium
Indication: T-Cell Lymphoma Stage IV
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-02
Patient:
Reactions: Neutropenia
Drug(s) suspected as cause:
Dexamethasone
Indication: T-Cell Lymphoma Stage IV
Elspar
Indication: T-Cell Lymphoma Stage IV
Etoposide
Indication: T-Cell Lymphoma Stage IV
Ifosfamide
Indication: T-Cell Lymphoma Stage IV
Methotrexate Sodium
Indication: T-Cell Lymphoma Stage IV
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-02
Patient:
Reactions: Neutropenia
Drug(s) suspected as cause:
Dexamethasone
Indication: T-Cell Lymphoma Stage IV
Elspar
Indication: T-Cell Lymphoma Stage IV
Etoposide
Indication: T-Cell Lymphoma Stage IV
Ifosfamide
Indication: T-Cell Lymphoma Stage IV
Methotrexate Sodium
Indication: T-Cell Lymphoma Stage IV
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-02
Patient:
Reactions: Neutropenia
Drug(s) suspected as cause:
Dexamethasone
Indication: T-Cell Lymphoma Stage IV
Elspar
Indication: T-Cell Lymphoma Stage IV
Etoposide
Indication: T-Cell Lymphoma Stage IV
Ifosfamide
Indication: T-Cell Lymphoma Stage IV
Methotrexate Sodium
Indication: T-Cell Lymphoma Stage IV
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-02
Patient:
Reactions: Neutropenia
Drug(s) suspected as cause:
Dexamethasone
Indication: T-Cell Lymphoma Stage IV
Elspar
Indication: T-Cell Lymphoma Stage IV
Etoposide
Indication: T-Cell Lymphoma Stage IV
Ifosfamide
Indication: T-Cell Lymphoma Stage IV
Methotrexate Sodium
Indication: T-Cell Lymphoma Stage IV
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-02
Patient:
Reactions: Neutropenia
Drug(s) suspected as cause:
Dexamethasone
Indication: T-Cell Lymphoma Stage IV
Elspar
Indication: T-Cell Lymphoma Stage IV
Etoposide
Indication: T-Cell Lymphoma Stage IV
Ifosfamide
Indication: T-Cell Lymphoma Stage IV
Methotrexate Sodium
Indication: T-Cell Lymphoma Stage IV
Possible Dexamethasone side effects in
Reported by a individual with unspecified qualification from United States on 2012-07-02
Patient:
Reactions: Neutropenia
Drug(s) suspected as cause:
Dexamethasone
Indication: T-Cell Lymphoma Stage IV
Elspar
Indication: T-Cell Lymphoma Stage IV
Etoposide
Indication: T-Cell Lymphoma Stage IV
Ifosfamide
Indication: T-Cell Lymphoma Stage IV
Methotrexate Sodium
Indication: T-Cell Lymphoma Stage IV
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-02
Patient:
Reactions: Bone Marrow Failure, Neutropenia, Bone Marrow Toxicity, Infection
Drug(s) suspected as cause:
Dexamethasone
Indication: T-Cell Lymphoma Stage IV
Elspar
Indication: T-Cell Lymphoma Stage IV
Etoposide
Indication: T-Cell Lymphoma Stage IV
Ifosfamide
Indication: T-Cell Lymphoma Stage IV
Methotrexate Sodium
Indication: T-Cell Lymphoma Stage IV
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-02
Patient:
Reactions: Neutropenia, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Dexamethasone
Indication: T-Cell Lymphoma Stage IV
Elspar
Indication: T-Cell Lymphoma Stage IV
Etoposide
Indication: T-Cell Lymphoma Stage IV
Ifosfamide
Indication: T-Cell Lymphoma Stage IV
Methotrexate Sodium
Indication: T-Cell Lymphoma Stage IV
Page 1 Next >>
|
